To include your compound in the COVID-19 Resource Center, submit it here.

Autoimmune company Cue raises $66.2 million IPO

Cancer and autoimmune company Cue Biopharma Inc. (NASDAQ:CUE) raised $66.2 million on Jan. 2 through

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE